Postural Tachycardia Syndrome (PoTS): A Panel Discussion

Published: 19 August 2020

  • Views:

    Views Icon 481
  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 481
  • Likes:

    Heart Icon 0

Overview

In this six-part video panel discussion, Prof Andrew Sharp meets with an expert panel to moderate discussion on the issues surrounding Postural Tachycardia Syndrome (PoTS) which is an abnormality of the automatic nervous system (dysautonomia) that results in abnormal heart rate increases upon standing or sitting.

 

For further information on PoTS, please visit PoTSUK.org.

The panellists have also written a helpful book on PoTS, available on Amazon.

Series overview

Part 1

Definition, Epidemiology & Diagnosis

Part one sees Prof Lesley Kavi (Birmingham City University, Birmingham, UK) discuss the main definitions, epidemiology and diagnosis.

1 session

  • Definition, Epidemiology & Diagnosis

    Watch now

Part 2

PoTs Sub-Types

Part two sees Prof Melvin Lobo (Barts BP Centre of Excellence, UK) discuss the various sub-types and mechanisms of PoTS with particular consideration of neuropathy, hyperadrenergic, and volume dysregulation.

1 session

Part 3

Comorbidities in PoTS

Part three sees Dr Nick Gall (King's College, London, UK) discuss the co-morbidities of PoTS.

1 session

Part 4

Non-Pharmacological Management of PoTS

Part four sees Prof Lesley Kavi (Birmingham City University, UK) discuss the non-pharmacological management of PoTS.

1 session

  • Non-Pharmacological Management of PoTS

    Watch now

Part 5

Drug Therapy of PoTS: Rhythm Control, Circulatory Control

Part five sees Prof Melvin Lobo (Bart's BP Centre of Excellence, UK) discuss drug therapy options in PoTs patients and the treatment options available according to subtype.

1 session

  • Drug Therapy of PoTS: Rhythm Control, Circulatory Control

    Watch now

Part 6

The Future of PoTs

The concluding video sees Dr Gall (King's College, UK) discuss what the future looks like for PoTS and examines why there is a need for more data and treatment options going forwards.

1 session

Faculty biographies